Food and Drug Administration (FDA) shortage declarations for semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)
Ozempic controversy: experts warn diabetes drug may cause weight gain and serious side effects Share your Subscriber Article You have 5 articles to share every month
Between 2023 and 2024, the number of medical weight-loss patients surged 137 percent, dramatically expanding the group of people experiencing the facial changes that can follow rapid weight loss
How Does the GLP-1 Patch Work
Given the potential implications of both GLP-1 level and FODMAP intake in IBS, researchers at the Haukeland University Hospital, Norway, investigated the impact of a low FODMAP diet on circulating GLP-1 levels in patients with IBS-diarrhea and IBS-mixed
Drug efflux transporters and multidrug resistance in acute leukemia: therapeutic impact and novel approaches to mediation